The prognosis evaluation of guideline-directed medical therapy for type 2 acute myocardial infarction patients with acute respiratory failure

Back

ESC Professional Premium Access

The prognosis evaluation of guideline-directed medical therapy for type 2 acute myocardial infarction patients with acute respiratory failure

Session: Acute heart failure and cardiogenic shock in acute coronary syndromes

Topic: Pharmacotherapy

Speaker: Professor K. Chen (Tianjin, CN)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Professor Kang-Yin Chen

2nd Hospital of Tianjin Medical University, Tianjin (China)

0 follower

6 more presentations in this session

VA-ECMO-related complications seem not causally related to mortality in patients with acute myocardial infarction complicated by cardiogenic shock

Speaker: Doctor T. Thevathasan (Berlin, DE)

STEMI SHOCK outcomes with SCAI classification

Speaker: Professor J. French (Sydney, AU)

Association of culprit lesions with in-hospital mortality in patients with acute coronary syndrome complicated by cardiogenic Shock

Speaker: Doctor S. Matsushita (Kurashiki, JP)

Do DAN-GER-SHOCK eligible patients benefit from VA-ECMO treatment in infarct-related cardiogenic shock ? Results of an individual patient data meta-analysis.

Speaker: Professor U. Zeymer (Ludwigshafen, DE)

Impact of inhaled nitric oxide therapy in patients with cardiogenic shock treated with veno-arterial extracorporeal membrane oxygenation combined with Impella

Speaker: Doctor M. Ueno (Osaka, JP) Doctor N. Yamada (Osaka, JP)

Access the full session

Acute heart failure and cardiogenic shock in acute coronary syndromes

Speakers: Professor K. Chen, Doctor T. Thevathasan, Professor J. French, Doctor S. Matsushita, Professor U. Zeymer...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources